Department of Periodontology, Faculty of Dentistry, Izmir Katip Çelebi University, Izmir, Turkey.
Clin Oral Investig. 2024 Jul 20;28(8):437. doi: 10.1007/s00784-024-05835-8.
Omega-3 supplementation as an adjunct to nonsurgical periodontal treatment has been reported to have a positive effect on healing in periodontitis patients. However, there is a lack of information on the effects of periodontal healing in smokers with periodontitis. The aim of this retrospective study was to investigate the effect of omega-3 supplementation given as an adjunct to nonsurgical periodontal treatment on clinical parameters in smoker and non-smoker periodontitis patients.
This study included a total of 80 periodontitis patients, 40 non-smokers and 40 smokers who were systemically healthy. In this study, patients were divided into 4 groups as follows: Group 1 (Subgingival instrumentation (SI) alone/nonsmoker), Group 2 (SI alone/smoker), Group 3 (SI + Omega-3/nonsmoker) and Group 4 (SI + Omega-3/smoker). Group 3 and 4 consumed 1320 mg Omega-3 capsule (640 mg EPA, 480 mg DHA) once a day for 3 months. Probing depth (PD), clinical attachment level (CAL), gingival index (GI), plaque index (PI) and bleeding on probing (BOP %) were recorded at baseline, 1 month and 3 months after treatment.
Significant improvement of all clinical parameters at 1 and 3 months was observed in all groups. Whole mouth CAL, GI and BOP% were significantly reduced in group 4 compared to group 2 at 1 and 3 months postoperatively (p < 0.05). For moderately deep pockets (4-6 mm) and deep pockets (7 mm≤), PD and CAL reductions were significantly greater in groups taking omega - 3 (group 3 and group 4) compared to groups not taking omega-3 (group 1 and group 2) between baseline and 1 month and between baseline and 3 months (p ˂ 0.05).
Omega-3 supplementation given as an adjunct to nonsurgical periodontal treatment provided significant benefit in the improvement of clinical parameters (especially for CAL and PD) in the short term in smokers and non-smokers with periodontitis.
Nonsurgical periodontal treatment with omega-3 supplementation resulted in significant improvements in clinical parameters in smokers and non-smokers with periodontitis.
有报道称,ω-3 补充剂作为非手术牙周治疗的辅助手段,对牙周炎患者的愈合有积极影响。然而,关于牙周炎吸烟者牙周愈合效果的信息仍然缺乏。本回顾性研究的目的是探讨ω-3 补充剂作为非手术牙周治疗的辅助手段,对吸烟者和非吸烟者牙周炎患者的临床参数的影响。
本研究共纳入 80 名牙周炎患者,其中 40 名不吸烟者和 40 名吸烟者,均为系统性健康者。在本研究中,患者被分为 4 组:第 1 组(单纯龈下刮治/非吸烟者)、第 2 组(单纯龈下刮治/吸烟者)、第 3 组(龈下刮治+ω-3/非吸烟者)和第 4 组(龈下刮治+ω-3/吸烟者)。第 3 组和第 4 组每天服用 1320mg ω-3 胶囊(640mg EPA、480mg DHA),持续 3 个月。在治疗前、治疗后 1 个月和 3 个月时记录探诊深度(PD)、临床附着水平(CAL)、牙龈指数(GI)、菌斑指数(PI)和探诊出血(BOP%)。
所有组在治疗后 1 个月和 3 个月时所有临床参数均有显著改善。与术后第 2 组相比,第 4 组术后 1 个月和 3 个月时全口 CAL、GI 和 BOP%均显著降低(p<0.05)。对于中度深袋(4-6mm)和深袋(7mm≤),在接受 ω-3 治疗的组(第 3 组和第 4 组)与未接受 ω-3 治疗的组(第 1 组和第 2 组)之间,在基线至 1 个月和基线至 3 个月之间,PD 和 CAL 的减少有显著差异(p<0.05)。
在牙周炎吸烟者和非吸烟者中,作为非手术牙周治疗辅助手段的 ω-3 补充剂在短期内对改善临床参数(特别是 CAL 和 PD)有显著效果。
牙周炎吸烟者和非吸烟者在接受牙周非手术治疗加用 ω-3 后,临床参数有显著改善。